Evidence map›Paper›PMID 31405030›Full record

ReviewBiomolecules2019

Insights on the Use of α-Lipoic Acid for Therapeutic Purposes.

Bahare Salehi, Yakup Berkay Yılmaz, Gizem Antika, Tugba Boyunegmez Tumer, Mohamad Fawzi Mahomoodally, Devina Lobine, Muhammad Akram, Muhammad Riaz, Esra Capanoglu, Farukh Sharopov and 3 more

2 registry-linked trialsOpen access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 186 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
186citing papers in PubMed, 5 pooled it
18.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05808946 phase2 / phase3unknown statusnot on this mapstarted 2023, after this paper: background citation

The Effect of Alpha-Lipoic Acid on the Clinical Outcome of Patients With Sepsis

TypeinterventionalSponsorAin Shams UniversityRan2023 to 2024Enrolled60ConditionsSepsisArmsAlpha-Lipoic Acid, Sepsis Supportive Care
NCT06902831 completednot on this mapstarted 2022, after this paper: background citation

Comparative Outcomes of Endoscopic and Open Carpal Tunnel Release with Neurotrophic Supplementation in Severe Carpal Tunnel Syndrome

TypeobservationalSponsorUniversity of BariRan2022 to 2024Enrolled497ConditionsCarpal Tunnel Syndrome (CTS)ArmsEndoscopic Carpal Tunnel Release, Open carpal tunnel release, Neurotrophic supplementation
3 · Its place in the literature

Who cites it

186 citing papers in PubMed, 5 syntheses or guidelines pooled it, 388 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Role of lipoic acid in multiple sclerosis.CNS neuroscience & therapeutics · 2022
    Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

126 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 10 institutions in 7 countries.

Bahare SalehiStudent Research Committee, School of Medicine, Bam University of Medical Sciences, Bam 44340847, Iran.ORCID 0000-0002-6900-9797
Yakup Berkay YılmazGraduate Program of Biomolecular Sciences, Institute of Natural and Applied Sciences, Canakkale Onsekiz Mart University, Canakkale 17020, Turkey.
Gizem AntikaGraduate Program of Biomolecular Sciences, Institute of Natural and Applied Sciences, Canakkale Onsekiz Mart University, Canakkale 17020, Turkey.
Tugba Boyunegmez TumerDepartment of Molecular Biology and Genetics, Faculty of Arts and Science, Canakkale Onsekiz Mart University, Canakkale 17020, Turkey.ORCID 0000-0002-1740-4867
Mohamad Fawzi MahomoodallyDepartment of Health Sciences; Faculty of Science, University of Mauritius, Réduit 80837, Mauritius.ORCID 0000-0003-3962-8666
Devina LobineDepartment of Health Sciences; Faculty of Science, University of Mauritius, Réduit 80837, Mauritius.ORCID 0000-0002-6398-0371
Muhammad AkramDepartment of Eastern Medicine, Government College University Faisalabad; Faisalabad 38000, Pakistan.ORCID 0000-0002-7457-8572
Muhammad RiazDepartment of Allied Health Sciences, Sargodha Medical College, University of Sargodha, Sargodha 40100, Pakistan.
Esra CapanogluFaculty of Chemical & Metallurgical Engineering, Food Engineering Department, Istanbul Technical University, Maslak 34469, Turkey.ORCID 0000-0003-0335-9433
Farukh SharopovDepartment of Pharmaceutical Technology, Avicenna Tajik State Medical University, Rudaki 139, Dushanbe 734003, Tajikistan. shfarukh@mail.ru.ORCID 0000-0003-0378-8887
Natália MartinsFaculty of Medicine, University of Porto, Alameda Prof. Hernâni Monteiro, 4200-319 Porto, Portugal.ORCID 0000-0002-5934-5201
William C ChoDepartment of Clinical Oncology, Queen Elizabeth Hospital, 30 Gascoigne Road, Hong Kong. chocs@ha.org.hk.ORCID 0000-0003-4174-4586
Javad Sharifi-RadZabol Medicinal Plants Research Center, Zabol University of Medical Sciences, Zabol 61615-585, Iran. javad.sharifirad@gmail.com.ORCID 0000-0002-7301-8151
Çanakkale Onsekiz Mart Üniversitesi · TRUniversity of Mauritius · MUBam University of Medical Sciences · IRGovernment College University, Faisalabad · PKIstanbul Technical University · TRQueen Elizabeth Hospital · CNTajik State Medical University · TJUniversidade do Porto · PTUniversity of Sargodha · PKZabol University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

α-lipoic acid (ALA, thioctic acid) is an organosulfur component produced from plants, animals, and humans. It has various properties, among them great antioxidant potential and is widely used as a racemic drug for diabetic polyneuropathy-associated pain and paresthesia. Naturally, ALA is located in mitochondria, where it is used as a cofactor for pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase complexes. Despite its various potentials, ALA therapeutic efficacy is relatively low due to its pharmacokinetic profile. Data suggests that ALA has a short half-life and bioavailability (about 30%) triggered by its hepatic degradation, reduced solubility as well as instability in the stomach. However, the use of various innovative formulations has greatly improved ALA bioavailability. The R enantiomer of ALA shows better pharmacokinetic parameters, including increased bioavailability as compared to its S enantiomer. Indeed, the use of amphiphilic matrices has capability to improve ALA bioavailability and intestinal absorption. Also, ALA's liquid formulations are associated with greater plasma concentration and bioavailability as compared to its solidified dosage form. Thus, improved formulations can increase both ALA absorption and bioavailability, leading to a raise in therapeutic efficacy. Interestingly, ALA bioavailability will be dependent on age, while no difference has been found for gender. The present review aims to provide an updated on studies from preclinical to clinical trials assessing ALA's usages in diabetic patients with neuropathy, obesity, central nervous system-related diseases and abnormalities in pregnancy.

Indexed as

AnimalsAntioxidantsBiological AvailabilityCentral Nervous System DiseasesDiabetic NeuropathiesHumansObesityThioctic AcidAntioxidantsThioctic Acidbioavailabilityclinical trialdiabetic neuropathyformulationsobesitypregnancyschizophreniasclerosisα-lipoic acid

Identifiers

PMID31405030
PMCPMC6723188
OpenAlexW2967446255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.